U C Wieshmann1, K Milinis2, J Paniker3, K Das4, M D Jenkinson5, A Brodbelt5, D Crooks2, S S Keller6. 1. Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK. Electronic address: udo.wieshmann@thewaltoncentre.nhs.uk. 2. Department of Neuropathology,The Walton Centre NHS Foundation Trust, Liverpool, UK. 3. Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK. 4. Department of Radiology, The Walton Centre NHS Foundation Trust, Liverpool, UK. 5. Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK. 6. Department of Radiology, The Walton Centre NHS Foundation Trust, Liverpool, UK; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Abstract
BACKGROUND: Some patients with oligodendrogliomas have generalized tonic-clonic seizures (GTCS) while others have only partial seizures (PS). We investigated the relationship between tumour localization and seizure generalization using quantitative lesion mapping on magnetic resonance images. METHODS: Twenty one patients with histologically proven oligodendrogliomas and GTCS (n=11) or PS (n=10) were studied. Data were acquired on a 3 Tesla MRI System. We performed lesion mapping techniques to compare the spatial distribution of oligodendrogliomas between patient groups, and quantitatively determined the extent to which lesions intersected each probabilistic regions-of-interest, including the cerebral lobes, thalamus, striatum, and genu of the corpus callosum. RESULTS: In patients experiencing GTCS, the greatest lesion load was observed in mesial frontal regions, including cortex connected to the genu. In contrast, the greatest lesion load in patients experiencing PS was observed more caudo-laterally in orbitofrontal and temporal lobes, but typically sparing cortex connected to the genu. The number of lesion intersections with genu region of interest was significantly greater in patients experiencing GTCS relative to patients with PS (p=0.03). There were no significant differences between patient groups with respect to lesion intersection with the individual cerebral lobes, thalamus and striatum, or with respect to overall oligodendroglioma size. CONCLUSION: Our data suggest that the genu of the corpus callosum may be a major pathway for seizure generalization in patients with oligodendrogliomas.
BACKGROUND: Some patients with oligodendrogliomas have generalized tonic-clonic seizures (GTCS) while others have only partial seizures (PS). We investigated the relationship between tumour localization and seizure generalization using quantitative lesion mapping on magnetic resonance images. METHODS: Twenty one patients with histologically proven oligodendrogliomas and GTCS (n=11) or PS (n=10) were studied. Data were acquired on a 3 Tesla MRI System. We performed lesion mapping techniques to compare the spatial distribution of oligodendrogliomas between patient groups, and quantitatively determined the extent to which lesions intersected each probabilistic regions-of-interest, including the cerebral lobes, thalamus, striatum, and genu of the corpus callosum. RESULTS: In patients experiencing GTCS, the greatest lesion load was observed in mesial frontal regions, including cortex connected to the genu. In contrast, the greatest lesion load in patients experiencing PS was observed more caudo-laterally in orbitofrontal and temporal lobes, but typically sparing cortex connected to the genu. The number of lesion intersections with genu region of interest was significantly greater in patients experiencing GTCS relative to patients with PS (p=0.03). There were no significant differences between patient groups with respect to lesion intersection with the individual cerebral lobes, thalamus and striatum, or with respect to overall oligodendroglioma size. CONCLUSION: Our data suggest that the genu of the corpus callosum may be a major pathway for seizure generalization in patients with oligodendrogliomas.
Authors: Ezequiel Gleichgerrcht; Adam S Greenblatt; Tanja S Kellermann; Nathan Rowland; W Alexander Vandergrift; Jonathan Edwards; Kathryn A Davis; Leonardo Bonilha Journal: Epilepsy Res Date: 2021-02-05 Impact factor: 3.045
Authors: Bibi L J Bouwen; Kay J Pieterman; Marion Smits; Clemens M F Dirven; Zhenyu Gao; Arnaud J P E Vincent Journal: Front Neurol Date: 2018-11-27 Impact factor: 4.003
Authors: Nishant Sinha; Natalie Peternell; Gabrielle M Schroeder; Jane de Tisi; Sjoerd B Vos; Gavin P Winston; John S Duncan; Yujiang Wang; Peter N Taylor Journal: Epilepsia Date: 2021-01-21 Impact factor: 6.740